A Phase 1b/2 Study of Hypofractionated Radiation (HD-XRT) and Combination Immunotherapy for REfractory Metastatic Melanoma
|Effective start/end date||5/1/17 → 9/1/23|
- PROMETHEUS LABORATORIES, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.